PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
1 clinical trials · Condition
◉ Watch PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer (NCT07111832) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2025-08-20 |
Track PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.